Adult Diapers market in the Americas to grow at a CAGR of 5.31% over the period 2014-2019; Finds New Report

Report forecast the Adult Diapers market in the Americas to grow at a CAGR of 5.31 percent over the period 2014-2019.

Adult diapers are necessary for people suffering from conditions such as urinary or fecal incontinence, mobility impairment, or dementia. The convenience and comfort offered by adult diapers has increased their acceptance among people. Adult diapers are easy to dispose and are comparatively a recent innovation, with the disposable diaper technology being evolving since the 1970s. The production of adult diaper is a multi-step process, in which the absorbent pad is vacuum-formed and attached with elastic fibers to fit the purpose.

Modern adult diapers and other incontinence products have brought a significant contribution and have changed the quality of life of millions of people. Pervasive in the acceptance and availability of adult diapers have provided better convenience, comfort, and skin care benefits for people affected by urinary incontinence. The introduction of modern adult diapers has improved steadily over decades through scientific advances.

This report covers the present scenario and the growth prospects of the Adult Diapers market in the Americas for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of different types of adult diapers. Adult diapers can be segmented based on the types:

• Flat Type
• Pad Type
• Pants Type

According to the report, improving economic conditions in the US and a rise in disposable income levels have resulted in increased demand for packaged foods and beverages. This has led to an increased demand for packaging solutions and products.

Further, the report states that one of the challenges in the market is the rising price of raw materials.

The Adult Diapers Market in the Americas 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the landscape of the Adult Diapers market in the Americas and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

key players in Adult Diapers Market in the Americas 2015-2019: Attends Healthcare Group, Hypermarcas S.A., Kimberly-Clark Corp, Paul Hartmann AG and Svenska Cellulosa Aktiebolaget (SCA)

Other Prominent Vendors in the market are: Covidien, Ever Green, McKesson, Medline, Ontex, P&G, Principle Business Enterprises and Unicharm

Key Countries

• Brazil
• US

Market Driver

• Growing Aging Population
• For a full, detailed list, view our report

Market Challenge

• Economic Burden of UUI
• For a full, detailed list, view our report

Market Trend

• Technological Advancements
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 103 pages and 43 Exhibits “Adult Diapers Market in the Americas 2015-2019” report covers Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Market Landscape, Key Leading Countries, Adult Diapers Specification, Product Segmentation of Adult Diapers Market in Americas, Reimbursement Scenario, Geographical Segmentation, Buying Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Key Vendor Analysis.

For further information on this report, please visit- http://mrr.cm/4Ps

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare

Adult Diapers Market in the APAC region to grow at a CAGR of 14.30% over the period 2014-2019; Finds New Report

Report forecast the Adult Diapers market in the APAC region to grow at a CAGR of 14.30 percent over the period 2014-2019.

An adult diaper is a disposable diaper that consists of an absorbent pad sandwiched between two non-woven fabric sheets. The sheets are designed to prevent the leakage, improve comfort, and retain the body fluid. Manufacturing of adult diaper is a multi-step process: the absorbent pad is vacuum formed, attached with elastic fibers to bring proper shape, so that it fits around leg and crotch. Modern adult diapers and other incontinence products have brought a significant contribution and have changed the quality of life of millions of people. Pervasive in the acceptance and availability of adult diapers has provided better convenience, comfort, and skin care benefits for people affected by urinary incontinence. The introduction of modern adult diapers has improved steadily over decades through scientific advances.

This report covers the present scenario and the growth prospects of the Adult Diapers market in the APAC region for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of different types of adult diapers. Adult diapers can be segmented based on the types, as mentioned below:

Pad-type Diapers

Pad-type diapers are the most consumable diapers and are shipped in large units worldwide. Pad-type diapers are considered to be the most comfortable diapers due to their design, material, and have high position comfort. They are more suitable for people suffering from light incontinence and can be changed accordingly as per the requirements of the user.

Pants-type Diapers

Pants-type adult diapers are often referred to as disposable or protective underwear for people suffering from incontinence. This kind of diaper has an absorbent lining with elastic bands around waist and legs to prevent leakage. Exclusive designs for men and women are also available. However, unisex models of pants-type adult diapers are gaining popularity as they are suitable for advanced odor protection and easy disposal.

Flat-type Diapers

Flat-type diapers are mostly used by youth/adults as they are available in different sizes with less puffiness or thickness and are easily foldable; they are rectangular or square in size. The major advantage of flat-type diaper is the layering and inserts, which can be easily adjustable and can be used as per the need of a user.

According to the report, the elderly are more susceptible to diseases that can cause incontinence. Therefore, a rise in the elderly population results in high demand for adult diapers for the management of the condition.

Further, the report states that the economic burden of UUI inhibits the growth of the adult diaper market in the APAC.

The Adult Diapers Market in the APAC Region 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the landscape of the Adult Diapers market in the APAC region and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

key players in the Adult Diaper Market in the APAC 2015-2019: Daio Paper Corp., Kimberly-Clark Corp., Nippon Paper Industries Co. Ltd., Svenska Cellulosa Aktiebolaget and Unicharm Corp.

Other Prominent Vendors in the market are: DSG International, First Quality Enterprises, Fu Burg Industrial, Kao, KCK Industries, Medline Industries, Ontex International and Principle Business Enterprises.

Key Countries

• China
• Japan
• Thailand

Key Vendors

• Daio Paper
• Kimberly-Clark
• Nippon Paper Industries
• Svenska Cellulosa Aktiebolaget (SCA)
• Unicharm

Other Prominent Vendor

• DSG International
• First Quality Enterprises
• Fu Burg Industrial
• Kao Corp
• KCK Industries
• Medline Industries
• Ontex International
• P&G
• Principle Business Enterprises

Market Driver

• Growing Aging Population
• For a full, detailed list, view our report

Market Challenge

• Economic Burden of UUI
• For a full, detailed list, view our report

Market Trend

• Demand from Emerging Markets
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 85 pages and 39 Exhibits “Adult Diaper Market in the APAC 2015-2019” report covers Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Market Landscape, Present and Future of Adult Diapers, Key Leading Countries, Specifications of Adult Diapers, Segmentation of Adult Diaper Market in APAC by Product, Buying Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Key Vendor Analysis.

For further information on this report, please visit- http://mrr.cm/4Pe

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare

PD-1 and PD-L1 inhibitors - Competitive Landscape, Pipeline and Market Analysis, 2015, New Report Launched

PD-1 and PD-L1 inhibitors - Competitive Landscape, Pipeline and Market Analysis, 2015 report analyses that PD-1 and PD-L1 inhibitors are among the highly targeted mechanisms in oncology. There are 34 drugs are in pipeline. Out of 34 drugs, 22 are in combinations with other therapeutics agents. Focus of development is mainly on the antibody-based interventions targeting programmed cell death protein 1 (PD-1) and Programmed death-ligand 1 (PD-L1). Continuation of expansion of the combination regimens is likely to be one of the main themes surrounding immunotherapies as these partnerships are the key to developing competitively strong therapy regimens.

According to Publisher, the future competitive landscape of PD-1 and PD-L1 inhibitors is estimated to be very strong. The market for PD-1 and PD-L1 drugs might be billions of dollars richer than many believe. These drugs which include Bristol-Myers' Opdivo and Merck's Keytruda, are going to be Blockbuster in upcoming years.

Scope

• Overview of PD-1 and PD-L1 inhibitors, role, significance, pathway, mechanism of action (MoA) and biomarkers of PD-1 and PD-L1 inhibitors
• The report has covered the worldwide market of PD-1 and PD-L1 inhibitors, information of marketed molecules including along with patent expiry and impact on market after expiry and detail profiling of Pipeline assets
• It also includes Indication wise detailed epidemiology along with trends in epidemiology, incidence and prevalence segmented in to major geographies
• Key topics covered include strategic competitor assessment, market characterization, opportunities, barriers and challenges in the market along with SWOT analysis of the PD-1 and PD-L1 inhibitors market
• Pipeline analysis: Comprehensive data split across different phases and emerging trends and comparative analysis of marketed and pipeline molecules, pipeline molecules with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with latest updates
• Analysis of the current and future market competition in the global PD-1 and PD-L1 inhibitors drug market. Current scenario of market with upcoming blockbuster molecules and their impact on overall market.

Reasons to Buy

• The report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of therapeutics under development for PD-1 and PD-L1 inhibitors.
• Develop business strategies by understanding the trends shaping and driving for Immunotherapeutics market
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Devise corrective measures for pipeline projects by understanding PD-a and PD-L1 inhibitors pipeline in-depth
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners to enhance and expand business potential and scope
• Identifying the upcoming leaders in the PD-1 and PD-L1 inhibitors market in the coming years.

Spanning over 85 pages, “PD-1 and PD-L1 inhibitors - Competitive Landscape, Pipeline and Market Analysis, 2015” report covers the Introduction, Executive Summary, Epidemiology, Market Overview, Combination therapy, Drug Candidate Profiles, SWOT Analysis, Market Research Methodology.

For further information on this report, please visit- http://mrr.cm/4P5

Find all Pharmacy Reports at: http://www.marketresearchreports.com/pharmacy

Anticoagulants-Competitive Landscape, Market & Pipeline Analysis, Forecasted Market Size 2015-2018, New Report Launched

Anticoagulants-Competitive Landscape, Market & Pipeline Analysis, Forecasted Market Size 2015-2018 report analyzes that Anticoagulants has lot of future scope and potential in the market. Mostly anticoagulants are being used in Venous Thromboembolism and Atrial Fibrillation. There are 16 anticoagulants in pipeline for venous thromboembolism, Atrial Fibrillation, Acute Coronary Syndrome, Stroke and Myocardial Infarction.

Publisher analysis predicts that global VTE therapeutics market was worth USD 4 billion in 2014 and expected to reach USD 5.5 billion by 2018 with a Compound Annual Growth Rate (CAGR) of 8.29%.

Publisher analysis forecasts that global Atrial Fibrillation market will reach on its peak value USD 13.28 billion in 2018 from USD 7.86 billion in 2014 with compound annual growth rate (CAGR) of 14%.

The Anticoagulants’ market is expected to decline after 2018 as many anticoagulants are going to be generic.

Scope

• Overview of Anticoagulants, which includes its physiology, pathophysiology, diagnosis and treatment.
• Report has covered the worldwide market of Anticoagulants, information of marketed molecules including patent expiry and detail profiling of Pipeline assets
• Anticoagulants annual sales and forecasted sales of major player still 2018
• Venous Thromboembolism and Atrial Fibrillation annual estimates and forecasts are provided along with historical analysis
• Detailed epidemiology for every region as well as trends in epidemiology and Information of Antidotes for Anticoagulants which are in pipeline
• Pipeline analysis: Comprehensive data split across different phases and emerging trends and therapeutic assessments by molecule type, route and mechanism of action
• Anticoagulant report includes strategic competitor assessment, market characterization, opportunities, barriers, challenges and regulatory hurdles for the Anticoagulants market.
• Analysis of the current and future market competition in the global Anticoagulants drug market. Insightful review of the key industry drivers, restraints and challenges.

Reasons to Buy

• The Anticoagulant report covers complete Market and Pipeline intelligence and understanding over therapeutics development for Anticoagulants
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of therapeutics under development for Anticoagulants
• Anti-coagulants report helps to develop business strategies by understanding the trends shaping and driving for Anticoagulants market
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Devise corrective measures for pipeline projects by understanding Anticoagulants pipeline in-depth
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners to enhance and expand business potential and scope
• Identifying the upcoming leaders in the Anticoagulants market in the coming years.

Spanning over 71 pages, “Anticoagulants-Competitive Landscape, Market & Pipeline Analysis, Forecasted Market Size 2015-2018” report covers the Introduction, Executive Summary, Marketed Drugs for Anticoagulants, Trends in epidemiology, SWOT Analysis, Market Research Methodology.

For further information on this report, please visit- http://mrr.cm/4PS

Find all Treatments Reports at: http://www.marketresearchreports.com/treatments

Wound Closure Devices - Pipeline Review, 2015, New Report Launched

Wound Closure Devices - Pipeline Review, 2015 report provides an overview of Wound Closure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key wound closure devices pipeline products.

Scope

• Extensive coverage of the Wound Closure Devices products under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Wound Closure Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Wound Closure Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product’s current stage of development, territory and estimated launch date

Spanning over 230 pages, “Wound Closure Devices - Pipeline Review, 2015” report covers the Introduction, Wound Closure Devices Overview, Products under Development, Wound Closure Devices - Pipeline Products by Stage of Development, Appendix, Methodology.

For further information on this report, please visit- http://mrr.cm/4dV

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

Drug Eluting Stents (DES) - Pipeline Review, 2015, New Report Launched

Drug Eluting Stents (DES) - Pipeline Review, 2015 report provides an overview of Drug Eluting Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key drug eluting stents pipeline products.

Scope

• Extensive coverage of the Drug Eluting Stents products under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Drug Eluting Stents and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Drug Eluting Stents under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product’s current stage of development, territory and estimated launch date

Spanning over 210 pages, “Drug Eluting Stents (DES) - Pipeline Review, 2015” report covers the Introduction, Appendix, Methodology.

For further information on this report, please visit- http://mrr.cm/4dH

Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices

Blood Glucose Meters - Pipeline Review, 2015, New Report Launched

Blood Glucose Meters - Pipeline Review, 2015 report provides an overview of Blood Glucose Meters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key blood glucose meters pipeline products.

Scope

• Extensive coverage of the Blood Glucose Meters products under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Blood Glucose Meters and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to buy

The report enables you to:

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Blood Glucose Meters under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product’s current stage of development, territory and estimated launch date

Spanning over 259 pages, “Blood Glucose Meters - Pipeline Review, 2015” report covers the Introduction, Products under Development, Blood Glucose Meters- Recent Developments, Appendix, Methodology.

For further information on this report, please visit- http://mrr.cm/4dK

Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices

Global Cushing’s Syndrome Treatment Market Value Soaring to Almost $500 Million by 2018, Finds New Report

The global Cushing’s Syndrome (CS) treatment market will expand rapidly in value from approximately $179 million in 2013 to $499 million by 2018, representing an impressive Compound Annual Growth Rate (CAGR) of 22.74%, according to new report.

The company’s latest report states that of the six major markets (6MM: the US, France, Germany, Italy, Spain and the UK), the US was the largest contributor to CS treatment revenues in 2013, generating around $129 million. The US will see this figure rocket to $371 million by 2018, claiming a 74% share of the global market.

Increasing disease prevalence will be a major driver behind the significant growth in the CS therapeutics arena, along with the arrivals of Novartis’ Signifor LAR (pasireotide), a more convenient dosing regimen for Signifor, in the 6MM in 2018 and HRA Pharma’s Ketoconazole HRA (ketoconazole) in Europe in 2015.

Senior Analyst covering Cardiovascular & Metabolic Disorders, says: “Additionally, the US launch of second-generation steroidogenesis inhibitors, such as Cortendo AB’s NormoCort (COR-003) and Novartis’ LCI699, will also boost the market over the forecast period.

“These two drugs will be heralded by physicians and patients alike, as they will satisfy the high unmet need for safer and more effective products targeting CS, namely severe forms of the condition.”

Despite these various products’ anticipated introductions into their respective markets, GlobalData believes that considerable opportunities remain for pharmaceutical and biotechnology companies to develop improved treatment options.

Senior Analyst continues: “The complex nature and limited understanding of CS, and in particular the pathophysiology behind Cushing’s disease, a subtype comprising the majority of CS patients, will continue to hinder the development of efficacious, safe and tolerable agents, especially ones targeting the root cause of Cushing’s disease. We therefore don’t expect the major unmet need for such drugs to be met fully by the end of the forecast period.

“However, the CS drug landscape is thought to be at a nascent stage of transformation with the arrival of Cortendo AB’s NormoCort (COR-003) and Novartis’ LCI699, which will provide relief to some concerns over current therapies,” the analyst concludes.

OpportunityAnalyzer: Cushing’s Syndrome - Opportunity Analysis and Forecasts to 2018 report provides annualized Cushing’s syndrome (CS) therapeutics market revenues, annual cost of therapies and treatment usage pattern data from 2013 and forecast for five years to 2018. The key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the CS therapeutics market.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by Publisher’s team of industry experts.

For further information on this report, please visit- http://mrr.cm/4dz

Find all Diseases Reports at: http://www.marketresearchreports.com/diseases

Global Irbesartan Industry Market 2015, New Report Now Available From MarketResearchReports.com

The Global Irbesartan Industry Report 2015 is a professional and in-depth study on the current state of the Irbesartan industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Irbesartan market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost price and production value gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Irbesartan industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 166 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 178 pages, “2015 Market Research Report on Global Irbesartan Industry” report covers the Irbesartan Industry Overview, Irbesartan Manufacturing Cost Structure Analysis, Irbesartan Technical Data and Manufacturing Plants Analysis, Irbesartan Production by Regions By Technology By Applications, Irbesartan Sales and Sales Revenue by Regions, 2010-2015 Irbesartan Productions Supply Sales Market Status and Forecast, Irbesartan Key Manufacturers Analysis, Price Gross Margin Analysis, Irbesartan Marketing Trader or Distributor Analysis, 2015-2020 Irbesartan Industry Development Trend, Irbesartan Industry Chain Suppliers and Contact Information Analysis, Irbesartan New Project Investment Feasibility Analysis, Global Irbesartan Industry Research Conclusions.

For further information on this report, please visit- http://mrr.cm/4de

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare

Global Human Immunoglobulin Industry Report 2015, New Report Launched

Global Human Immunoglobulin Industry Report 2015 is a professional and in-depth study on the current state of the Human Immunoglobulin industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Human Immunoglobulin market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Human Immunoglobulin industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Human Immunoglobulin industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 206 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 143 pages, “Global Human Immunoglobulin Industry Report 2015” report covers the Human Immunoglobulin Industry Overview, Global Human Immunoglobulin Market Status Analysis, Major Regions Human Immunoglobulin Market Status Analysis, Major Countries Human Immunoglobulin Market Status and Analysis, Major Companies Human Immunoglobulin Market Status and Analysis, Human Immunoglobulin Industry Chain and Marketing Channels Analysis, Human Immunoglobulin Industry Segment Market Analysis, Human Immunoglobulin Industry Development Trend, Human Immunoglobulin New Project Investment Feasibility Analysis, Global Human Immunoglobulin Industry Research Conclusions.

For further information on this report, please visit- http://mrr.cm/4ds

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare

Global and China Meropenem Industry Market 2015, New Report Now Available From MarketResearchReports.com

The Global Meropenem Industry Report 2015 is a professional and in-depth study on the current state of the Meropenem industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Meropenem market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Meropenem industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Meropenem industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 140 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 150 pages, “2015 Market Research Report on Global and China Meropenem Industry” report covers the Meropenem Industry Overview, Meropenem Manufacturing Cost Structure Analysis, Meropenem Technical Data and Manufacturing Plants Analysis, Meropenem Production by Regions By Technology By Applications, Meropenem Sales and Sales Revenue by Regions, 2010-2015 Meropenem Productions Supply Sales Market Status and Forecast, Meropenem Key Manufacturers Analysis, MeropenemPrice Gross Margin Analysis, Meropenem Marketing Trader or Distributor Analysis, 2015-2020 Meropenem Industry Development Trend, Meropenem Industry Chain Suppliers and Contact Information Analysis, Meropenem New Project Investment Feasibility Analysis, Global Meropenem Industry Research Conclusions.

For further information on this report, please visit- http://mrr.cm/4AX

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare

Global Pompe Disease market to grow at a CAGR of 11.79% over the period 2014-2019; Finds New Report

Report forecast the Global Pompe Disease market to grow at a CAGR of 11.79 percent over the period 2014-2019.

Pompe disease is a type of LSD. LSD refers to a group of diseases arising from the accumulation of specific substrates. LSDs are progressive and have variable age of onset and clinical symptoms. LSDs are inherited autosomal recessive disorders. Pompe disease has two broad sub-types: infantile-onset Pompe disease and adult-onset Pompe disease. Pompe disease occurs as a result of mutations in the GAA gene. These mutations are responsible for the preventing the action of the enzyme acid alpha-glucosidase, which is responsible for catabolizing glycogen, thereby allowing sugar to accumulate and reach toxic levels in the lysosomes of cells. The buildup of glycogen in certain organs and tissues, mostly in the muscles, hinders the normal functions of organs. Pompe disease is an autosomal recessive disease. This implies that both the parents pass on one abnormally mutated copy of the gene to their child. A parent carrying an abnormal copy of the gene is known as a carrier. Pompe disease affects both men and women, irrespective of the gender. Pompe disease affects people across all ethnicities and races. Individuals affected with Pompe disease acquire the disease at birth, however, the onset of symptoms varies extensively. More than 300 genetic mutations that can cause Pompe disease have been identified by the researchers till date. Though there is no cure for Pompe disease, diet therapy and enzyme replacement therapy are effective in reducing the clinical manifestations of the disease.

This report covers the present scenario and the growth prospects of the Global Pompe Disease market for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of drugs available in the market for the management of Pompe disease.

The report also presents the vendor landscape and a corresponding detailed analysis of the major vendors in the Global Pompe Disease market. The report also considers the revenue that is likely to be generated from the drug candidates that are under various phases of development. In addition, it discusses the major drivers that influence the growth of the market, the challenges faced by the vendors and the market at large, as well as the key trends that contribute to the growth the market. 

According to the report, special provisions allocated to drugs for orphan diseases have a positive impact on market growth. Incentives in the form of funding, guidance, and marketing exclusivity provide attractive opportunities to vendors to conduct research in this disease area. For instance, the drug Myozyme was designated as an orphan drug by the FDA in 1997.

Further, the report states that a limited patient population hinders the effective evaluation of drugs based on clinical trials. The presence of few affected people has a negative impact on drug sales and prolongs the time period by which a vendor can recover the R&D expenses of the drug.

Global Pompe Disease Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Pompe Disease market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key players in the Global Pompe Disease Market: Amicus Therapeutics Inc., BioMarin Pharmaceutical Inc. and Genzyme Corp

Other Prominent Vendors in the market are: Audentes Therapeutics, EpiVax, Oxyrane, Sangamo BioSciences and Valerion Therapeutics

Key Regions

• Americas
• APAC
• EMEA    

Market Driver

• Special Provisions for Orphan Drugs
• For a full, detailed list, view our report

Market Challenge

• Limited Patient Population
• For a full, detailed list, view our report

Market Trend

• Regulatory Assistance in Emerging Nations
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 71 pages, “Global Pompe Disease Market 2015-2019” report covers the Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Market Landscape, Disease Overview, Pipeline Analysis, Geographical Segmentation, Buying Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Key Vendor Analysis.

For further information on this report, please visit- http://mrr.cm/4QC

Find all Diseases Reports at: http://www.marketresearchreports.com/diseases